These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2505284)

  • 1. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity.
    Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL
    Psychopharmacology (Berl); 1989; 98(4):448-52. PubMed ID: 2505284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats.
    Aulakh CS; Cohen RM; Hill JL; Murphy DL; Zohar J
    Br J Pharmacol; 1987 Aug; 91(4):747-52. PubMed ID: 3664076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anorexic responses to m-chlorophenylpiperazine during lithium administration to fawn-hooded rats.
    Aulakh CS; Hill JL; Murphy DL
    Pharmacol Biochem Behav; 1994 Nov; 49(3):759-62. PubMed ID: 7862734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    Neuroendocrinology; 1993 May; 57(5):869-74. PubMed ID: 8413823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes.
    Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL
    Eur J Pharmacol; 1988 Jun; 150(3):239-46. PubMed ID: 2901357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat.
    Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL
    Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term imipramine treatment differentially affects fenfluramine-induced suppression of food intake and locomotor activity.
    Aulakh CS; Wozniak KM; Hill JL; Murphy DL
    Pharmacol Biochem Behav; 1988 Sep; 31(1):97-101. PubMed ID: 3252266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
    Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
    Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
    Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
    Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.
    Aulakh CS; Hill JL; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1988; 95(3):313-7. PubMed ID: 3137616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats.
    Aulakh CS; Haass M; Zohar J; Wozniak KM; Hill JL; Murphy DL
    Pharmacol Biochem Behav; 1989 Jan; 32(1):37-42. PubMed ID: 2734349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced hypophagia and hyperthermia in rats is mediated by serotonin-2A receptors.
    Aulakh CS; Mazzola-Pomietto P; Wozniak KM; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1994 Jul; 270(1):127-32. PubMed ID: 8035308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I; Ward HR; Frazer A
    J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of feeding and locomotion responses to serotonin agonists in three rat strains.
    Aulakh CS; Hill JL; Murphy DL
    Pharmacol Biochem Behav; 1988 Nov; 31(3):567-71. PubMed ID: 2977992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
    Gleason SD; Shannon HE
    Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
    Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term administration of m-chlorophenylpiperazine to rats does not alter functional sensitivity of either pre-synaptic or postsynaptic 5-HT1A receptors.
    Aulakh CS; Hill JL; Tolliver TJ; Marcantonio D; Murphy DL
    J Psychopharmacol; 1991 Jan; 5(2):142-8. PubMed ID: 22282366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine.
    Cohen RM; Aulakh CS; Murphy DL
    Eur J Pharmacol; 1983 Oct; 94(1-2):175-9. PubMed ID: 6653658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion.
    Ulrichsen J; Partilla JS; Dax EM
    Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fawn hooded rats are subsensitive to the food intake suppressant effects of 5-HT agonists.
    Wang P; Aulakh CS; Hill JL; Murphy DL
    Psychopharmacology (Berl); 1988; 94(4):558-62. PubMed ID: 2967518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.